CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to UNCY

Oxylanthanum Carbonate

Phase 2
Unicycive Therapeutics, Inc. (UNCY)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Chronic Kidney Disease Requiring Chronic Dialysis

View Full Landscape
Drug Information

Target Indication

Chronic Kidney Disease Requiring Chronic Dialysis

Clinical Trial

NCT06218290

Last updated: 12/4/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Dec 1, 2030(4y 3m)

Patents Listed

2

Application

NDA 204734
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.